| NATERA INC. DL-,0001 |
| USA |
| Gesundheit |
| US6323071042 / A14VPJ |
| 45E (Frankfurt) / NTRA (NASDAQ) |
| FRA:45E, ETR:45E, 45E:GR, NASDAQ:NTRA |
| - |
| https://www.natera.com/ |
|
Natera, Inc. is a molecular diagnostics company that develops and commercializes cell-free DNA and genetic testing services for clinical use. The company focuses on oncology, women’s health, and organ health, using proprietary molecular assays and ..
>Volltext.. |
| 42701.84 Mio. EUR |
| 41954.28 Mio. EUR |
| 2346.34 Mio. EUR |
| -190.65 Mio. EUR |
| -166.71 Mio. EUR |
| -1.19 EUR |
| 206.71 Mio. EUR |
| 946.05 Mio. EUR |
| 197.82 Mio. EUR |
| 1.97 |
| 42.15% |
| 21.66% |
| - |
| - |
| - |
| 4 Insider verkauften innerhalb der letzten 30 Tage Aktien im Wert von 21.777.636 Euro. |
| NATERA |
| 17.09.26 |
|
||||
|